Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Risk Reduction Behavior × Estrogens, Conjugated (USP) × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Hot Flashes 3 Risk Reduction Behavior 1 Prostatic Neoplasms 1 Osteoporosis 1 Focus of Study is Healthy Women at Risk for Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1

Interventions

College Fraternities and Sororities 2 bazedoxifene 1 Tamoxifen 1 Risk Assessment 1 Radon 1 Price Transparency 1 Nutrition Assessment 1 Exercise 1 Estrogens, Conjugated (USP) 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡